Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (34)

2024

  1. Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers

    Biomedicines, Vol. 12, Núm. 3

2023

  1. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index

    Cancers, Vol. 15, Núm. 13

  2. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index

    PLoS ONE, Vol. 18, Núm. 10 OCTOBER

  3. Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

    Biomedicines, Vol. 11, Núm. 12

  4. Telomere Length and Telomerase Activity in Subcutaneous and Visceral Adipose Tissues from Obese and Non-Obese Patients with and without Colorectal Cancer

    Cancers, Vol. 15, Núm. 1

2021

  1. Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment

    Molecular and Clinical Oncology, Vol. 15, Núm. 3

2016

  1. Clinical relevance of telomere status and telomerase activity in colorectal cancer

    PLoS ONE, Vol. 11, Núm. 2

2015

  1. Prognostic value of telomere function in gastric cancers with and without microsatellite instability

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 2, pp. 162-169

  2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

    Journal of Experimental and Clinical Cancer Research, Vol. 34, Núm. 1

2014

  1. B-ring-aryl substituted luotonin A analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity

    PLoS ONE, Vol. 9, Núm. 5

2012

  1. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition

    Oncology, Vol. 82, Núm. 3, pp. 153-164

  2. Methylation profiling in non-small cell lung cancer: Clinical implications

    International Journal of Oncology, Vol. 40, Núm. 3, pp. 739-746

2011

  1. Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells

    Cancer Microenvironment, Vol. 4, Núm. 1, pp. 23-32

2010

  1. APC Yin-Yang haplotype associated with colorectal cancer risk

    Experimental and Therapeutic Medicine, Vol. 1, Núm. 5, pp. 879-883

  2. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215

2008

  1. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability

    Clinical Cancer Research, Vol. 14, Núm. 4, pp. 995-1001

  2. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer

    Lung Cancer, Vol. 60, Núm. 3, pp. 416-425

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223

  2. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

  3. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma

    Oncology Reports, Vol. 17, Núm. 6, pp. 1301-1307